Industry News - Tag: RB
You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
6 May 2019
Worldwide OTC sales at RB dropped by 9% on a like-for-like basis to GBP470 million (USD603 million) in the first quarter of 2019. The company blamed an "unusually weak cold and flu season across the US and several European markets" plus "associated retailer destocking".
26 February 2019
RB is set to launch a dietary supplement for "brain performance" in the US in April 2019. The company said Neuriva would be the "first brand in brain health to offer a holistic ecosystem that supports brain performance".
25 February 2019
RB's Health division reported worldwide sales up by 4% on a like-for-like basis to GBP2.07 billion (USD2.74 billion) in the fourth quarter of 2018. The company said e-commerce now generated around 9% of sales by the division.